Table 2.
ncRNAs targeting Mafs in cancer
Cancer types | ncRNAs | Mafs | Functions of the interaction | Reference |
---|---|---|---|---|
Osteosarcoma | miR-4660 | MafG | Inhibits Osteosarcoma cell growth | [70] |
Lung adenocarcinoma | lncRNA MAFG-AS1 | MafG | Suppresses the proliferation and induce apoptosis of lung adenocarcinoma cells | [71] |
miR-7 | MafG | Restores resistance to cisplatin | [72] | |
Prostate cancer | lncRNA EIF3J-AS1 | MafG | Promotes proliferation and metastatic ability of prostate cancer cells | [73] |
Oral cancer | LINC00284 | MafG | Promotes cell proliferation and migration of oral squamous cell carcinoma | [74] |
Laryngocarcinoma | miR-1290 | c-Maf | Suppresses apoptosis of laryngeal squamous cell carcinoma cells | [75] |
Neurofibroma | miR-155 | c-Maf | Promotes tumor growth in plexiform neurofibroma | [76] |
Multiple myeloma | lncRNA ANGPTL1-3 | c-Maf | Increases bortezomib sensitivity of multiple myeloma cells | [10] |
Nasopharyngeal carcinoma | miR-223 | MafB | Inhibits cell proliferation and migration of nasopharyngeal carcinoma | [77] |
Liver cancer | circ-ITCH | MafF | Inhibits the proliferation and induces cell apoptosis of hepatocellular carcinoma | [78] |
cia-MAF | MafF | Impairs tumorigenesis, self-renewal and metastatic capacities in liver cancer | [79] |